SPX -0.58% VIX 4.38%
WAR OF WILL WINS 144TH PREAKNESS IN RACE THAT INCLUDED RIDERLESS HORSE
MICHIGAN GOP CONGRESSMAN SEEN AS FIRST OF PARTY TO SAY TRUMP ACTS IMPEACHABLE
AOC STANDS WITH BUFFETT: CEO NET WORTH SHOULD TAKE A HIT IF BAILOUT GIVEN
JOE BIDEN PITCHES HIMSELF AS A UNITER EVEN AS HE TEARS INTO TRUMP
HERE'S THE STOCK PLAY BOOSTED BY 'GAME OF THRONES' BANDWIDTH HOGS
THE TARIFF TIFF AND A FED RETHINK ARE JUST TWO AREAS OF STOCK-MARKET ANGST
ECONOMIC PREVIEW: CONSUMER SPENDING SLOWS, INVESTMENT HURT BY CHINA TRADE WAR
STRATEGIST: A NUMBER OF INDICATORS SUGGEST THE STOCK MARKET COULD EXTEND GAINS
AUSTRALIAS RULING CONSERVATIVE COALITION APPEARS HEADED TO A SURPRISE WIN
U.S. STOCKS END LOWER FOR DAY AND WEEK ON U.S.-CHINA TRADE UNCERTAINTY
Sun, May 19 9:09am



Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Biogen Inc [BIIB]
$229.28 1.59 (0.69%)

BIIB Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 44.91 Billion
BIIB Description

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.


Visit Website

BIIB Earnings

EPS 7.17 P/E Ratio 10.77
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Wed, Apr 24, 2019 (25 days ago)

BIIB Dividend

Yield --
Ex-Date --
Pay Date --
History --

BIIB Charts

$216.71
52 Week Range
$383.83
Mar 22, 2019
Jul 25, 2018

229.28 44.91 10.77 0.00 BIIB NASDAQ -0.69 -24.75 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIIB&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIIB&exchange=NASDAQ&chart=1

Symbol Price % YTD
BIIB $229.28 -0.69% -24.75%


Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy